People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| X-Vax Technology, Inc. | — | Biotechnology | Series C | $56.6M | $2.3B | 2018 |
Isaac T. Blech at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Isaac T. Blech on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Blech | 1 | 14 |
| Robert Ruffolo | 1 | 8 |
| Brian D. Finn | 1 | 4 |
| Roger J. Pomerantz | 1 | 4 |
| Roger Pomerantz | 1 | 4 |
| Ian T. Clark | 1 | 2 |
| William A Haseltine | 1 | 2 |
| Jacob Uittenbogaard | 1 | 2 |
| Matthew R. Stober | 1 | 2 |
| Roger A. Jeffs | 1 | 2 |
| Ulf Wiinberg | 1 | 1 |
| Andreas Eggert | 1 | 1 |
| Clare Kahn | 1 | 1 |
| Richard Kenney | 1 | 1 |
| Robert R. Ruffolo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.